Manzeneder Johannes, Römmele Christoph, Manzeneder Carolin, Ebigbo Alanna, Messmann Helmut, Goelder Stefan Karl
Department of Internal Medicine III at the University Hospital Augsburg, Germany.
Gastroenterol Res Pract. 2021 Mar 16;2021:9237617. doi: 10.1155/2021/9237617. eCollection 2021.
Flexible endoscopic treatment plays an important role in the treatment of Zenker's diverticulum (ZD). This study analyzes long-term symptom control and the rate of adverse events in treatment-naïve patients and patients with recurrence, using the stag beetle knife junior (sb knife jr).
From August 2013 to May 2019, 100 patients with symptomatic ZD were treated with flexible endoscopy using the sb knife jr. Before treatment, as well as 1 and 6 months afterwards, symptoms were obtained by a nine-point questionnaire, with symptoms weighted from 0 to 4.
Overall, 126 interventions were performed. The median follow-up period was 41 months (range 7-74). For the three most frequent symptoms, regurgitation, dysphagia, and dry cough, a significant reduction of the mean score could be achieved, from 2.85/3.45/2.85 before the initial treatment to 0.56/1.09/0.98 6 months later. 17 patients were retreated because of recurrence. Out of these, 12 patients underwent a 2, 4 patients a 3, and 1 patient a 4 session, respectively. The mean dysphagia score for successfully treated patients could be reduced from initially 2.34 to 0.49/0.33/0.67 after the 1/2/3 session, the frequency of dysphagia from 3.45 to 0.92/1.00/1.33, and the score for regurgitations from 2.85 to 0.35/1.00/0.67. In first-line treatment, as well as in retreatment, no severe adverse event occurred.
Patients with ZD can be treated safely and effectively with the sb knife jr. Retreatment leads to equal symptom relief as compared to a successful first-line treatment and is not associated with a higher rate of adverse events.
柔性内镜治疗在Zenker憩室(ZD)的治疗中发挥着重要作用。本研究使用鹿角锹形刀二代(sb knife jr)分析初治患者和复发患者的长期症状控制情况及不良事件发生率。
2013年8月至2019年5月,100例有症状的ZD患者接受了使用sb knife jr的柔性内镜治疗。治疗前以及治疗后1个月和6个月,通过九点问卷获取症状,症状权重为0至4。
共进行了126次干预。中位随访期为41个月(范围7 - 74个月)。对于三种最常见的症状,反流、吞咽困难和干咳,平均得分可显著降低,从初始治疗前的2.85/3.45/2.85降至6个月后的0.56/1.09/0.98。17例患者因复发接受再次治疗。其中,12例患者接受了2次治疗,4例患者接受了3次治疗,1例患者接受了4次治疗。成功治疗患者的平均吞咽困难评分从最初的2.34降至第1/2/3次治疗后的0.49/0.33/0.67,吞咽困难频率从3.45降至0.92/1.00/1.33,反流评分从2.85降至0.35/1.00/0.67。在一线治疗和再次治疗中,均未发生严重不良事件。
使用sb knife jr可安全有效地治疗ZD患者。与成功的一线治疗相比,再次治疗能同样缓解症状,且不良事件发生率不高。